GSDMD and colitis: Studies have shown that PD‐L1 promotes Gasdermin D (GSDMD)‐mediated NET release.[26] We found that the colons of mice with colitis expressed high levels of PD‐L1, while treatment with Bf‐OMVs significantly downregulated PD‐L1 expression (Figure9a).